Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In GI Oncology GI Oncology for January/February 2021 Younger adults present with more advanced esophageal adenocarcinoma, PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival, More must reads GI Oncology for May/June 2020 AGA clinical practice update: Pancreatic cancer screening, More must readsGI Oncology for March/April 2020 Bariatric surgery may curtail colorectal cancer risk, Molecularly guided therapy in pancreatic cancer: Untapped potential and the ‘bright future’ ahead, Colorectal cancer burden rises in younger age groups, Preoperative chemoradiotherapy failed to boost overall survival in pancreatic cancer, Review reveals shorter OS, RFS in young colorectal cancer patients, More must readsGI Oncology for January/February 2020 Large study probes colonoscopy surveillance intervals, Mailed fecal testing may catch more cancer than endoscopic screening, GALAD score predicts NASH-HCC more than a year in advance, Unique T cell populations pinpointed in hepatocellular carcinoma tissue, More must readsGI Oncology for November/December 2019 Loss of pancreatic E-cadherin contributes to carcinogenesis, More must readsPages1 2 3 4 last »
